Patient outcomes - ResMed Middle-East
COVID-19
Middle-East (English)
COVID-19
Close

Patient outcomes

RLD-patient-outcomes-resmed

 

NIV has been shown to improve daytime arterial blood gases and the symptoms associated with respiratory failure in patients with a chest wall disorder.1

  • Improved gas exchange with increased PO2 and decreased PCO2
  • Improved hemodynamics with decreased pulmonary artery pressure and increased right ventricular function
  • Reduced work of breathing
  • Normalised sleep patterns with fewer apneic episodes.
  • Fewer hospital admissions
  • Improved quality of life
  • Relief from dyspnoea

Reference

  1. Nickol AH, Hart N, Hopkinson NS, Moxham J, Simonds A, Polkey MI. (2005) Mechanisms of improvement of respiratory failure in patients with restrictive thoracic disease treated with non-invasive ventilation. Thorax Sep; 60(9):754-60